Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
for Major Depressive Disorder (MDD)
Sites in Garden Grove, Orange +17 more locations
Sponsor: Vanda Pharmaceuticals
Sex: All·Age: 18 - 65
Code: NCT06830044·Phase 3·Recruiting·Listed Feb 2025